Sharekhan

Healthcare Global Enterprises Ltd

Fri 22/05/2026,15:55:45 NSE: HCG

₹ 654.30 27.30 (4.35%)
BUY NOW Buy Healthcare Global Enterprises Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Healthcare Global Enterprises Ltd

Fri 22/05/2026,16:1:0

Healthcare Global Enterprises Ltd

Fri 22/05/2026,15:55:45 | NSE : HCG

₹ 654.3027.30 (4.35%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 627.95

Previous Close

₹ 627.00

Volume

400146

Mkt Cap ( Rs. Cr)

₹9768.84

High

₹ 661.00

Low

₹ 627.95

52 Week High

₹ 788.39

52 Week Low

₹ 513.30

Book Value Per Share

₹ 90.11

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Healthcare Global Enterprises Ltd

Your Vote -

Buy

61.54%

Hold

23.08%

Sell

15.38%

61.54%

13 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

654.30

134

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

134

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Healthcare Global Enterprises Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Healthcare Global - Copy of Newspaper Publication

    21 May 2026, 1:18PM Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication of Audited Financial Results of the company.

  • Healthcare Global - Analysts/Institutional Investor Meet/Con. Call Updates

    20 May 2026, 5:49PM Healthcare Global Enterprises Limited has informed the Exchange about Link of Recording of the Earnings Call held on Wednesday, May 20, 2026.

  • Healthcare Global - Statement of deviation(s) or variation(s) under Reg. 32

    20 May 2026, 12:19AM Healthcare Global Enterprises Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    20 May 2026, 5:51PM Further to our intimation dated May 07, 2026, we would like to inform you that the Audio recording of the Earnings Call with Analysts/Investors held o

  • Healthcare Global - Statement Of Deviation Or Variation Of The Proceeds Of Rights Issue For The Quarter Ended March 31, 2026.

    20 May 2026, 12:17AM Statement of Deviation or Variation of the proceeds of Rights Issue for the quarter ended March 31, 2026.

  • Healthcare Global - Memorandum of Understanding/Agreements

    19 May 2026, 11:49PM HealthCare Global Enterprises Limited (the Company) has entered into a Share Purchase Agreement (SPA) dated May 19, 2026, with BACC Health Care Privat

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    19 May 2026, 11:44PM The Company has entered into a Share Purchase Agreement with Inviga Healthcare Fund I in relation to the divestment by way of sale of the entire equit

  • Healthcare Global - Press Release

    19 May 2026, 11:36PM Healthcare Global Enterprises Limited has informed the Exchange regarding a press release dated May 19, 2026, titled Press release on Annual Financial

  • Healthcare Global - Investor Presentation

    19 May 2026, 11:36PM Healthcare Global Enterprises Limited has informed the Exchange about Investor Presentation

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 May 2026, 11:30PM Press release on Annual Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026.

  • Healthcare Global - Appointment

    19 May 2026, 11:27PM Healthcare Global Enterprises Limited has informed the Exchange regarding Re-appointment of Mr Rajiv Maliwal as Non- Executive Independent Director of

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Investor Presentation

    19 May 2026, 11:27PM Investor Presentation on the Annual Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026.

  • Healthcare Global - Re-Appointment Of Internal Auditor Of The Company

    19 May 2026, 11:21PM The Board of Directors of the Company at their meeting held on May 19, 2026, has approved the re-appointment of Mr. Vijay S Shanbhag as the Internal A

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Change in Management

    19 May 2026, 11:18PM The Board of Directors at their meeting held on May 19, 2026, has approved the appointment of Mr. Ravi Gothwal as AVP- Investor Relations, who shall b

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Change in Management

    19 May 2026, 11:15PM The Board of Directors of the Company at their meeting held on May 19, 2026, has approved the appointment of Mr. Sanjeev Kumar as the Chief Financial

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Change in Directorate

    19 May 2026, 11:12PM The Board of Directors of the Company approved the re-appointment of Mr. Rajiv Maliwal (DIN: 00869035) as a Non-Executive Independent Director of the

  • Healthcare Global - General Updates

    19 May 2026, 11:11PM The Board of Directors of the Company has, at their meeting held today, i.e., May 19, 2026, approved the divestment by way of sale of HealthCare Globa

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

    19 May 2026, 11:05PM The Board of Directors of the Company has approved the divestment by way of sale of its entire equity shareholding in its wholly owned subsidiary- BAC

  • Healthcare Global Q4 net profit down 84.93% at Rs 1.53 cr

    19 May 2026, 11:00PM The company reported standalone net profit of Rs 1.53 crore for the quarter ended March 31, 2026 as compared to Rs 10.15 crore in the same period last

  • Healthcare Global - Audited Financial Results For The Quarter And Year Ended March 31, 2026.

    19 May 2026, 10:52PM Audited Financial Results for the quarter and year ended March 31, 2026.

  • Healthcare Global - Outcome of Board Meeting

    19 May 2026, 10:46PM This is to inform that the Board of Directors of the Company at its meeting held on May 19, 2026, has, inter alia, considered and approved the Audited

  • Healthcare Global - Board Meeting Outcome for Outcome Of The Board Meeting_19.05.2026

    19 May 2026, 10:43PM The Company has announced the Outcome of the Board meeting held on May 19, 2026, including approval of audited financial results of the Company for th

  • Healthcare Global - Capacity addition

    19 May 2026, 1:28PM Healthcare Global Enterprises Limited has informed the Exchange regarding launch of its new comprehensive cancer hospital in Hebbal with up to 132 bed

  • Healthcare Global - Press Release

    19 May 2026, 1:10PM Healthcare Global Enterprises Limited has informed the Exchange regarding a press release dated May 19, 2026, titled ""HealthCare Global Enterprises L

  • Healthcare Global - Intimation Regarding Launch Of New Comprehensive Cancer Hospital Of The Company In Hebbal, North Bangalor

    19 May 2026, 1:29PM The Company hereby informs the exchanges that it has today launched its new comprehensive cancer hospital in Hebbal, with up to 132 beds, strengthenin

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 May 2026, 1:08PM HealthCare Global Enterprises Limited (HCG), India's largest dedicated cancer hospital network, today announced the launch of its new comprehensive ca

  • Healthcare Global - Monitoring Agency Report

    13 May 2026, 1:23PM Monitoring Agency Report for the quarter ended March 31, 2026 - in relation to the Rights Issue of the Company.

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    13 May 2026, 1:24PM Monitoring Agency Report for the quarter ended March 31, 2026- in relation to the Rights Issue of the Company.

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    7 May 2026, 12:16PM Further to the intimation submitted to Stock Exchanges dated May 01, 2026, with respect to the meeting of the Board of Directors of the Company, to be

  • Healthcare Global - Analysts/Institutional Investor Meet/Con. Call Updates

    7 May 2026, 12:16PM Healthcare Global Enterprises Limited has informed the Exchange about Earnings Conference Call that has been scheduled on Wednesday, May 20, 2026, at

  • Healthcare Global - Board Meeting Intimation for Considering And Approving Inter-Alia, The Audited Financial Results (Both St

    1 May 2026, 12:27PM Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to

  • Healthcare Global - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    22 Apr 2026, 10:42AM Healthcare Global Enterprises Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Healthcare Global - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    22 Apr 2026, 10:34AM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

  • Healthcare Global has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    17 Apr 2026, 6:30PM As of March 2026, 64.21% is owned by Promoters and 35.79% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 9.94% and Forei

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    13 Apr 2026, 7:57PM The Company has informed the Exchange about completion of acquisition of additional 34% shares of Vizag Hospital and Cancer Research Centre Private Li

  • Healthcare Global - General Updates

    13 Apr 2026, 7:56PM Healthcare Global Enterprises Limited (the Company) has informed the Exchange about completion of acquisition of additional 34% shares of Vizag Hospit

  • Healthcare Global has submitted to BSE the Shareholding Pattern for the Period Ended March 27, 2026

    3 Apr 2026, 7:00AM As of March 2026, 64.21% is owned by Promoters and 35.79% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 9.94% and Forei

  • Healthcare Global - Trading Window

    31 Mar 2026, 6:11PM Healthcare Global Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)

  • Healthcare Global - Copy of Newspaper Publication

    30 Mar 2026, 4:47PM Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication in respect of Special Window for Transfer and Dema

  • Healthcare Global - Copy of Newspaper Publication

    30 Mar 2026, 4:33PM Healthcare Global Enterprises Limited has informed the Exchange about Issue of advertisement in newspapers in respect of certain matters such as detai

  • Healthcare Global - Outcome of Board Meeting

    30 Mar 2026, 3:59PM Intimation regarding approval for investments in (i) HCG NCHRI Oncology LLP, wholly owned subsidiary for up to Rs. 98 Crore and (ii) Vizag Hospital an

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Acquisition

    30 Mar 2026, 3:52PM Intimation regarding approval for investments in (i) HCG NCHRI Oncology LLP, wholly owned subsidiary for up to Rs. 98 Crore and (ii) Vizag Hospital an

  • Healthcare Global - Amendment(s)

    29 Mar 2026, 2:19PM Intimation regarding the execution of the (i) Second Amendment Agreement to the Share Purchase Agreement entered into for the acquisition of shares of

  • Healthcare Global - Committee Meeting Updates

    27 Mar 2026, 10:24PM This is in continuation to the meetings of the Board of Directors ( Board ) of HealthCare Global Enterprises Limited ( Company ) held on February 17,

  • Healthcare Global - Rights Issue

    27 Mar 2026, 10:16PM This is in continuation to the meetings of the Board of Directors ( Board ) of HealthCare Global Enterprises Limited ( Company ) held on February 17,

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Allotment

    27 Mar 2026, 10:13PM The Rights Issue Committee at its meeting held today, i.e., March 27, 2026, inter alia, considered and approved the allotment of 82,94,566 Equity Shar

  • Healthcare Global - General Updates

    26 Mar 2026, 6:10PM Healthcare Global Enterprises Limited has informed the Exchange that Healthcare Global (Tanzania) Private Limited ( HCG Tanzania ), a non-operating wh

  • Healthcare Global - Intimation Regarding Winding Up Of Healthcare Global (Tanzania) Private Limited, Wholly Owned Indirect Su

    26 Mar 2026, 6:02PM This is to inform that, the HealthCare Global (Tanzania) Private Limited, a non-operating wholly owned indirect subsidiary of the Company incorporated

  • Healthcare Global - Copy of Newspaper Publication

    6 Mar 2026, 5:26PM Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication of advertisements in respect of certain matters re

  • Healthcare Global - General Updates

    25 Feb 2026, 12:59AM Healthcare Global Enterprises Limited has informed the Exchange about the Letter of Offer dated February 24, 2026 for Rights Issue of fully paid-up eq

  • Healthcare Global - Corporate Action- Record Date For Rights Issue.

    24 Feb 2026, 8:11PM The Company has informed the Exchange that the Record Date fixed for the purpose of Rights Issue is March 02, 2026.

  • Healthcare Global - Record Date

    24 Feb 2026, 8:10PM Healthcare Global Enterprises Limited has informed the Exchange that Record date fixed for the purpose of Rights issue is 02-Mar-2026.

  • Healthcare Global - Rights Issue

    24 Feb 2026, 8:07PM Healthcare Global Enterprises Limited has informed the Exchange that Board of Directors at its meeting held on February 24, 2026, has decided to issue

  • Healthcare Global - Announcement under Regulation 30 (LODR)-Raising of Funds

    24 Feb 2026, 8:04PM The Board of Directors of the Company at its meeting held today, February 24, 2026, has decided to issue equity shares on rights basis in the ratio of

  • Healthcare Global - Rights Issue

    24 Feb 2026, 8:01PM Healthcare Global Enterprises Limited has informed the Exchange that Board of Directors at its meeting held on February 24, 2026, has decided to issue

  • Healthcare Global - Board Meeting Outcome for Outcome Of Board Meeting- Rights Issue

    24 Feb 2026, 7:56PM The Board of Directors of the Company at its meeting held today, February 24, 2026, has decided to issue equity shares on rights basis in the ratio of

  • Healthcare Global Enterprises

    11 Sep 2025 , 1:20PM Healthcare Global Enterprises : Aceso Company, part of the CVC Network, has sold nearly a 6% stake in the company via a block deal on the NSE, raising Rs.552 crore at an average price of Rs. 695 per share. Of the 79 lakh shares sold, Nippon India Mutual Fund bought 44 lakh shares worth Rs. 306 crore, increasing its stake by 3.2% on top of the 2.5% it already held as of June 2025. Other buyers included Plutus Wealth Management (Rs. 50 crore), Axis Mutual Fund (Rs. 66 crore), and Morgan Stanley Asia Singapore (₹61 crore). Motilal Oswal AMC also picked up three lakh shares worth Rs. 21 crore.

  • Healthcare Global Enterprises

    24 Feb 2025 , 9:03AM American private-equity giant KKR & Co will acquire up to a 54 per cent stake in hospital chain Healthcare Global Enterprises (HCG) from CVC Asia V for $400 million (approximately Rs 3,465 crore). KKR will purchase shares of HCG at Rs 445 apiece (11% discount to CMP) and make an open offer to the company’s shareholders to buy an additional 26 per cent. Negative

  • Healthcare Global to acquire majority stake in Vizag Hospital

    28 Jun 2024 , 1:54PM The company shall acquire a further 34% stake at Rs. 155 crore

  • Healthcare Global Enterprises

    27 Sep 2023 , 10:01AM According to media reports, Private equity firm CVC Capital Partners is considering selling a 60.4% stake in Indian cancer hospital chain HealthCare Global Enterprises. The stake is worth about $345 million (currently value at Rs2885crore). CVC may seek a premium of 20% for the shares or go as high as 50% depending on market conditions.

  • Healthcare Global Enterprises

    7 Jul 2023 , 11:22AM The Company entered into a Share Purchase Agreement with Dr Ajay Mehta, Dr Suchitra Mehta and shareholders of NCHRI, for the acquisition of entire equity share capital in Nagpur Cancer Hospital & Research Institute Pvt. Ltd (NCHRI). The completion of the acquisition is subject to the receipt of requisite approvals by NCHRI and other conditions. HCG currently holds 76% stake in the 115 beds Hospital. Post the acquisition it will be 100% subsidiary of the company. The cost of acquisition of entire shares (100%) in NCHRI would be INR 14.1 Crores, and the consideration payable to Dr.Ajay Mehta for the transfer of his partnership interest in HCG NCHRI LLP would be INR 17.6 Crores (which includes deferred consideration of INR 4.2 Crores). The turnover of NCHRL in FY2023 stood at ~Rs8crore with EBIDTA of Rs7.6crore.

  • Viewpoint: Healthcare Global Enterprises

    23 Mar 2023 , 2:06PM Viewpoint: Healthcare Global Enterprises – Improved growth visibility with favourable risk-reward

  • View Point: Healthcare Global Enterprises

    13 Dec 2022 , 11:09AM View Point: Healthcare Global Enterprises - Drivers in place to achieve consistent growth

  • Healthcare global enterprises

    2 Dec 2022 , 10:35AM Care rating has revised upwards the rating for the company to Care A+; Outlook – stable from Care A; outlook – stable. The revision in the rating assigned to the bank facilities of the company factors in the strong recovery in admissions and procedures performing translating into sustained improvement in its revenues and profitability – Positive read thru; preferred stock in the Hospital space.

  • Healthcare Global Enterprises

    20 Sep 2022 , 11:31AM BACC Health Care Private Limited (“Milann”), Wholly Owned Subsidiary of Healthcare Global Enterprises (HCG), is in discussions with Neonatal Care & Research Institute Private Limited (“Ovum”) with respect to a proposal for entering into a business combination arrangement, whereby HCG, post the completion of the Transaction, may hold a majority of the shareholding in the resultant entity. Ovum Hospitals, run by the Neonatal Care & Research Institute (NCRI), is an organization formed by a group of doctors with national and international experience in the field of pediatrics and gynaecology. It has around five centres in an around the city of Bangaluru.

  • Viewpoint: Healthcare Global

    27 Jun 2022 , 10:33AM Viewpoint: Healthcare Global - Bed capacity expansion and improved profitability to drive growth ahead

  • Healthcare Global Enterprises

    24 Jun 2022 , 10:34AM Healthcare Global Enterprises: The company Acquires radiant hospitals in Odisha, like to acquire majority stake in Cancer hospital in Nagpur

  • Healthcare Global Enterprises

    24 Jun 2022 , 9:42AM The company Acquires radiant hospitals in Odisha, like to acquire majority stake in Cancer hospital in Nagpur and setting 25 bed capacity in Bangalore and expanding Ahmedabad hospital bed capacity (10-11% addition in the bed capacity 1720 over the next two years).

  • HCG acquires majority stake in Suchirayu HealthCare Solutions

    22 Nov 2021 , 10:02AM Acquisition of majority stake in Suchirayu Health care Solutions, Hubli, Karnataka.

  • Viewpoint: Healthcare Global - Q2FY22

    15 Nov 2021 , 2:13PM Viewpoint: Healthcare Global - Q2FY22 consolidated results review

  • HCG Q2FY022 consolidated

    12 Nov 2021 , 10:32AM Healthcare Global Enterprises: (HCG) Q2FY022 consolidated – strong operating performance

  • Healthcare Global Enterprises

    13 Oct 2021 , 9:56AM Healthcare Global Enterprises: Operations return to regular level post second wave; revenue stream at all time high

  • Healthcare Global Enterprises

    29 Sep 2021 , 12:16PM ICRA has upgraded long term – term loan/cash credit /overdraft to A+ (stable) from A- and on short term – non-fund based to A1 from A2+ - Positive read through for Healthcare Global Enterprises

  • Viewpoint: Healthcare Global Enterprises

    17 Sep 2021 , 9:58AM Viewpoint: Healthcare Global Enterprises - Unique business model to drive healthy cash flows

  • Healthcare Global Enterprises

    16 Sep 2021 , 10:50AM Rating agency care has upgraded rating of long term bank facilities of Rs489.2crore to Single A and Outlook stable – Positive read through for the stock.

  • HealthCare Global acquires oncology hospital labs from Strand Lifesciences

    6 Sep 2021 , 2:35PM HCG acquires oncology labs and divests stake in Strand Lifesciences to Reliance

  • Healthcare Global Enterprises

    6 Sep 2021 , 10:23AM The company acquires oncology labs & clinical trial business strand Lifesciences and simultaneously divested 38.5% stake in Strand to Reliance Industries HCG focusing on oncology, acquired oncology hospital labs and clinical trials business from Strand Lifesciences and simultaneous divestment of its ~38.5% stake (on paid-up capital basis and 34.5% on fully diluted basis) in Strand to Reliance Industries. HCG received consideration of ~INR 157cr for sale of its ownership in Strand and acquired labs and clinical research business through a Business Transfer Agreement (BTA) from Strand for a consideration of ~INR 81cr with a set-off of ~INR 7cr towards receivables. The transactions resulted in net cash inflow of ~INR 83cr for HCG in addition to the take-over of the labs and clinical research business. Strand will no longer continue to be an associate company of HCG post completion of this transaction

  • Healthcare Global board approves preferential allotment

    23 Nov 2017 , 11:17AM Healthcare Global announces that it will issue 11.66 lakh shares at Rs300 each on a preferential basis to Indgrowth Capital Fund 1

  • Healthcare Global to set up 12 hospitals in 18 months

    23 Aug 2017 , 9:18AM Healthcare Global Enterprises (HCG) plans to set up a dozen new hospitals over the next 18 months - positive read through for the stock.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Healthcare Global Enterprises Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 2171.83 1842.61 1584.073 1266.619 1205.14
Liabilities 2171.83 1842.61 1584.073 1266.619 1205.14
Equity 149.3 139.416 139.29 139.116 139.012
Gross Profit 241.59 215.316 196.251 180.262 149
Net Profit 14.58 3.527 33.959 40.191 38.253
Cash From Operating Activities 160.19 145.951 194.709 130.396 124.395
NPM(%) 1.06 0.27 3.08 3.99 4.48
Revenue 1365.3 1280.489 1099.29 1005.573 851.961
Expenses 1123.71 1065.173 903.039 825.311 702.961
ROE(%) 1.08 0.26 2.52 2.98 2.84

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Healthcare Global Enterprises Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 705.80 -0.07 0.00 373.11 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 109.19 1.26 352.23 1359.56 3.55 0.00
Vaishali Pharma Ltd 7.00 0.14 0.00 8528.96 3.13 0.00
Astec Lifesciences Ltd 771.80 4.77 0.00 1282.09 -363.15 0.00

Company Info

The Company was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a private limited company under the Companies Act, 1956. The name of the Company was subsequently changed to HealthCare Global Enterprises Private Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on November 14, 2005. the Company was converted into a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on May 20, 2006 and the name of the Company was changed to HealthCare Global Enterprises Limited. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued by the RoC on July 5, 2006. Major events and milestones of the Company : 2005 -Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited 2006 -India Development Fund made its first investment of 500 million in the Company -BMORCL became the Subsidiary 2007 -HCG Medi-Surge became the Subsidiary -Evolvence made its first investment of 225 million in the Company 2008 -NTICPL made its first investment of 400 million in the Company 2009 -Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company 2010 -IL&FS Trust Company Limited a/c MPEF, through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company 2011 -Amalgamation of BMORCL with the Company -PIOF became a Shareholder by purchasing shares from NTICPL 2013 -V-Sciences made its first investment of `600 million in the Company -Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare 2014 -Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company 2015 -HCG Regency became the Subsidiary -Amalgamation of HCG Vijay with the Company -HCG was recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India in 2015 for its in-house research and development activities at HCG Towers, Bengaluru. -At Frost and Sullivan 7th Annual Indian Healthcare Excellence Awards in 2015, Milann was recognised as the `Emerging IVF Service Provider Company of the Year'. 2016 -Company has entered into a Joint Venture Agreement on November 22, 2016, with HCG Regency Oncology Healthcare Pvt. Ltd -All India Critical Care Hospital Ranking Survey - 2016 -HCG Launches Advanced Comprehensive Cancer Centre in Baroda -Launch of HCG Vizag -HCG inaugurates TomoTherapy at its Centre of Excellence -HCG - The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2017 -HCG The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2018 -Healthcare Global Enterprises Limited has approved the Scheme of Amalgamation of DKR with BACC on January 29, 2018 (?the Scheme?). BACC is a subsidiary of the Company, and DKR is a wholly owned subsidiary of BACC. -HCG Hospitals, Bhavnagar was recognised as the `Best Multispeciality Hospital' in Bhavnagar by Saurashtra Samachar in 2018. -HCG Cancer Centre, Ahmedabad was awarded as the `Best Cancer Hospital' by DivyaBhaskar in 2018. 2019 -Milann has been honoured with The National Icon Award 2018-19 for being `India's Most Trusted IVF Centre'. 2020 -During the 6th India Health and Wealth Awards in 2020, HealthCare Global Enterprises Ltd was recognised for its efficient COVID management initiatives. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. 2021 -Three centres from the HCG network, namely Bangalore, Mumbai and Vadodara bagged 1st, 3rd and 6th positions under the National Single Speciality - Oncology category in the Times Health's All India Critical Care Hospital Ranking Survey 2021. -Milann has been recognised as `The Best Fertility and IVF Chain in India' by ET Healthcare Brands. -HCG Cancer Centre, Ahmedabad, has been honoured with the Times Healthcare Leaders Ahmedabad 2021 Awards for `Excellence in Oncology' and `Excellence in Innovative Technology'. -HCG Cancer Centre, Ahmedabad, was ranked amongst the World's Best Hospitals 2021 by Newsweek Magazine. 2023 -HCG Cancer Hospital collaborates with Intuitive to deepen accessibility of Robotic-Assisted Surgery across India -HealthCare Global Enterprises Limited becomes India's first mercury-free cancer care chain of hospitals. 2024 -The Company completed of acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited. -Healthcare Global Enterprises Ltd (HCG) partners with Trucan Diagnostics to Pioneer New Diagnostic Tests for Treatment Response Prediction and Monitoring in Cancer Patients. -HCG expands with two new state-of-the-art cancer care centres in Bengaluru. -HCG recognized as the Champion of India 2024 at the prestigious Dun & Bradstreet 'ESG Leadership Summit 2024'

The Company was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a private limited company under the Companies Act, 1956. The name of the Company was subsequently changed to HealthCare Global Enterprises Private Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on November 14, 2005. the Company was converted into a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on May 20, 2006 and the name of the Company was changed to HealthCare Global Enterprises Limited. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued by the RoC on July 5, 2006. Major events and milestones of the Company : 2005 -Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited 2006 -India Development Fund made its first investment of 500 million in the Company -BMORCL became the Subsidiary 2007 -HCG Medi-Surge became the Subsidiary -Evolvence made its first investment of 225 million in the Company 2008 -NTICPL made its first investment of 400 million in the Company 2009 -Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company 2010 -IL&FS Trust Company Limited a/c MPEF, through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company 2011 -Amalgamation of BMORCL with the Company -PIOF became a Shareholder by purchasing shares from NTICPL 2013 -V-Sciences made its first investment of `600 million in the Company -Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare 2014 -Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company 2015 -HCG Regency became the Subsidiary -Amalgamation of HCG Vijay with the Company -HCG was recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India in 2015 for its in-house research and development activities at HCG Towers, Bengaluru. -At Frost and Sullivan 7th Annual Indian Healthcare Excellence Awards in 2015, Milann was recognised as the `Emerging IVF Service Provider Company of the Year'. 2016 -Company has entered into a Joint Venture Agreement on November 22, 2016, with HCG Regency Oncology Healthcare Pvt. Ltd -All India Critical Care Hospital Ranking Survey - 2016 -HCG Launches Advanced Comprehensive Cancer Centre in Baroda -Launch of HCG Vizag -HCG inaugurates TomoTherapy at its Centre of Excellence -HCG - The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2017 -HCG The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2018 -Healthcare Global Enterprises Limited has approved the Scheme of Amalgamation of DKR with BACC on January 29, 2018 (?the Scheme?). BACC is a subsidiary of the Company, and DKR is a wholly owned subsidiary of BACC. -HCG Hospitals, Bhavnagar was recognised as the `Best Multispeciality Hospital' in Bhavnagar by Saurashtra Samachar in 2018. -HCG Cancer Centre, Ahmedabad was awarded as the `Best Cancer Hospital' by DivyaBhaskar in 2018. 2019 -Milann has been honoured with The National Icon Award 2018-19 for being `India's Most Trusted IVF Centre'. 2020 -During the 6th India Health and Wealth Awards in 2020, HealthCare Global Enterprises Ltd was recognised for its efficient COVID management initiatives. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. 2021 -Three centres from the HCG network, namely Bangalore, Mumbai and Vadodara bagged 1st, 3rd and 6th positions under the National Single Speciality - Oncology category in the Times Health's All India Critical Care Hospital Ranking Survey 2021. -Milann has been recognised as `The Best Fertility and IVF Chain in India' by ET Healthcare Brands. -HCG Cancer Centre, Ahmedabad, has been honoured with the Times Healthcare Leaders Ahmedabad 2021 Awards for `Excellence in Oncology' and `Excellence in Innovative Technology'. -HCG Cancer Centre, Ahmedabad, was ranked amongst the World's Best Hospitals 2021 by Newsweek Magazine. 2023 -HCG Cancer Hospital collaborates with Intuitive to deepen accessibility of Robotic-Assisted Surgery across India -HealthCare Global Enterprises Limited becomes India's first mercury-free cancer care chain of hospitals. 2024 -The Company completed of acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited. -Healthcare Global Enterprises Ltd (HCG) partners with Trucan Diagnostics to Pioneer New Diagnostic Tests for Treatment Response Prediction and Monitoring in Cancer Patients. -HCG expands with two new state-of-the-art cancer care centres in Bengaluru. -HCG recognized as the Champion of India 2024 at the prestigious Dun & Bradstreet 'ESG Leadership Summit 2024'

Read More

Parent Organisation

Healthcare Global Enterprises Ltd.

Founded

12/03/1998

Managing Director

Dr.Manish Mattoo

NSE Symbol

HCGEQ

FAQ

The current price of Healthcare Global Enterprises Ltd is ₹ 654.30.

The 52-week high for Healthcare Global Enterprises Ltd is ₹ 661.00 and the 52-week low is ₹ 627.95.

The market capitalization of Healthcare Global Enterprises Ltd is currently ₹ 9768.84. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Healthcare Global Enterprises Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Healthcare Global Enterprises Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Healthcare Global Enterprises Ltd shares.

The CEO of Healthcare Global Enterprises Ltd is Dr.Manish Mattoo, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

Invest Better, Trade Faster — Install Now.

Mirae Asset Sharekhan App

Recommended

Open App

Browser

Continue
OPEN FREE* DEMAT ACCOUNT